KANSAS: KU Receives $5.8 Million for Phase 3 of Infectious Disease COBRE

NIH awarded the University of Kansas $5.8 million for Phase 3 of its infectious disease COBRE, supporting investigators and shared research capacity across Kansas institutions while preparing the center for long-term sustainability.